Why let biotech have all the fun? In keeping with a trend of smaller firms raising buckets of cash using Big Pharma’s cast-off drugs, Pfizer Inc. is adapting the strategy for itself by spinning off four pipeline drugs into a new company called SpringWorks Therapeutics.
